We are live on ! Find out more
LNAI

Lunai Bioworks

22 hedge funds and large institutions have $982K invested in Lunai Bioworks in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

10% more funds holding

Funds holding: 2022 (+2)

0.53% more ownership

Funds ownership: 0.06%0.59% (+0.53%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

29% less capital invested

Capital invested by funds: $1.38M → $982K (-$399K)

Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
5
Reduced
7
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
-$107 -12 -67%
DB
27
Danske Bank
Denmark
-$81 -7 Closed
Citigroup
28
Citigroup
New York
-$47 -4 Closed
EWA
29
EverSource Wealth Advisors
Alabama
-$7 -1 Closed

LNAI Hedge Fund Activity: Q4 2025 in Review

22 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q4 2025, worth a combined $982K — down 29% from $1.38M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new LNAI positions and 5 closed out — a net gain of 2 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Nine Masts Capital, opening a new position worth an estimated $27K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $53.6K sold.

  • 22 institutional investors held Lunai Bioworks (LNAI) as of Q4 2025, up from 20 in Q3 2025.
  • Funds reported $982K of Lunai Bioworks stock for Q4 2025, down 29% quarter-over-quarter.
  • 7 funds opened new Lunai Bioworks positions in Q4 2025 and 5 closed out, a net change of +2 holders.
  • The largest Lunai Bioworks buyer in Q4 2025 was Nine Masts Capital, an estimated $27K added.
  • The largest Lunai Bioworks seller in Q4 2025 was Renaissance Technologies, an estimated $53.6K sold.

Based on aggregated 13F filings for Q4 2025.